Souradipto Ghosh Dastidar

Associate Consultant

United States4 yrs 7 mos experience

Most Likely To SwitchHighly Stable

Key Highlights

Fifth-year doctoral student in Biostatistics.
Research focused on Bayesian analysis and machine learning.
Interned at prestigious institutions in Germany and the USA.

Stackforce AI infers this person is a Biostatistics expert with a focus on healthcare analytics.

Contact

souradip127gd@gmail.com LinkedIn

Skills

Core Skills

BiostatisticsStatistical ModelingStatistical Genetics

Other Skills

Data AnalysisLaTeXMATLABPublic HealthPublic SpeakingR (Programming Language)

About

I am a fifth year doctoral student at the Department of Biostatistics, University of Minnesota School of Public Health. My research interests broadly revolve around Bayesian analysis, data integration and machine learning. Prior to this, I completed the Master of Statistics and Bachelor of Statistics degrees from Indian Statistical Institute, Kolkata in 2021 and 2019 respectively. In the summers of 2019 and 2020, I worked as a summer research intern at the Bioinspired Communication Systems Lab, Technical University of Darmstadt, Germany under Prof. Heinz Koeppl.

Experience

Eli lilly and company

PhD Statistician Intern

May 2025 – Aug 2025 · 3 mos · Indianapolis, Indiana, United States

Fda

FDA-OCE-ASA Oncology Educational Fellowship

Oct 2024 – May 2025 · 7 mos

The FDA-OCE-ASA Oncology Educational Fellowship is a collaborative endeavor of the Food and Drug Administration’s Oncology Center of Excellence (FDA-OCE), the American Statistical Association (ASA), and the ASA’s Biopharmaceutical Statistics Section (BIOP). The program is aimed to provide the opportunity for statistics and biostatistics graduate students and post-doctoral fellows to learn about oncology drug development and regulatory policy.

Novartis

Biostatistician

Jun 2023 – Aug 2023 · 2 mos · Cambridge, Massachusetts, United States

Retrospective analysis on the use of tumor size to predict overall survival in non-small cell lung cancer (NSCLC) patients. Worked on internal Novartis data to assess surrogacy of tumor size and quantify the effect of greater tumor reduction on survival benefit